Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
$11.18−0.46 (-3.95%)
Close on Nov 19, 2026Market cap $1.45BP/E –Yield –
Mesoblast free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -$44.66M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$44.66M | – |
| FY2025 | Jun 30, 2025 | -$50.63M | – |
| FY2024 | Jun 30, 2024 | -$48.73M | – |
| FY2023 | Jun 30, 2023 | -$63.53M | – |
See a number that looks wrong?